{"schema_version":"secwatch.filing_event.v1","accession":"0001145197-24-000031","form_type":"8-K","ticker":"PODD","cik":"0001145197","company_name":"INSULET CORP","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.292012+00:00","generated_at":"2026-05-31T15:55:15.574671+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Insulet Q2 preliminary revenue $488M (+23% YoY), raises FY Omnipod guidance to 18-21%","bullets":["Q2 revenue $488M, up 23% YoY, exceeding guidance of 15-18% constant currency growth.","Total Omnipod revenue $480M (+26%): US $352M (+27%), International $128M (+23%, +24% CC).","Drug Delivery revenue $8M.","Raises FY 2024 total Omnipod revenue growth outlook to 18-21% from prior 15-19%.","Full Q2 results and call scheduled for August 8, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001145197-24-000031","json":"https://secwatch.observer/filing/0001145197-24-000031.json","markdown":"https://secwatch.observer/filing/0001145197-24-000031.md","text":"https://secwatch.observer/filing/0001145197-24-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1145197/000114519724000031/0001145197-24-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1145197/000114519724000031/podd-20240726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:55:15.574671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}